Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $1.15T | 40.5x | 1.56 | $42.71 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $57.01B | 26.8x | 3.67 | $189.43 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.9% Upside | Upgrade to Pro+ | |
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $21.10B | 22.3x | -10.26 | $95.72 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $10.57B | 16.4x | -2.11 | $45.03 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $2.37B | 24x | 0.22 | $10.04 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $2.23B | 16.9x | 11.18 | $46.57 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.7% Upside | Upgrade to Pro+ | |
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $423.56M | -0.8x | 0 | $1.18 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $363.53M | -6.7x | -0.23 | $7.93 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $296.90M | -66.6x | -0.76 | $3.67 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $210.15M | -1.1x | 0.04 | $0.72 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $210.15M | -1.1x | 0.04 | $0.72 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $172.25M | -27.7x | -2.06 | $2.77 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.9% Upside | Upgrade to Pro+ | |
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $152.83M | -2.5x | -0.04 | $0.47 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $152.83M | -2.5x | -0.04 | $0.47 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $109.15M | 69.3x | -0.94 | $1.07 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $63.32M | -30x | 0.93 | $0.54 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $62.71M | -3.1x | 0 | $0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $27.01M | -5.7x | 0.02 | $0.22 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $23.83M | -2.5x | -0.09 | $0.83 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $18.91M | 23.2x | $21.61 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $18.91M | 23.2x | -2.59 | $231.42 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $18.91M | 23.2x | -2.59 | $22.65 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $18.91M | 23.2x | -2.59 | $22.78 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $18.91M | 23.2x | 66.63 | $230.95 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nass Valley Gateway | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $11.62M | -7.5x | $0.04 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $10.56M | -0.1x | 0 | $0.04 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $10.01M | -10.6x | -0.13 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanadaBis Capital | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $9.68M | 35x | -0.48 | $0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $9.49M | -0.1x | -0.01 | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $9.32M | -0.5x | -0.01 | $3.02 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $7.27M | -0.2x | -0.02 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $7.27M | -0.2x | -0.02 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $4.30M | -18x | 0.06 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $3.99M | -4.7x | -0.08 | $0.010 | -33.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ORAGIN Foods | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $3.12M | -1x | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Entourage Health | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $1.54M | -0x | -0 | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ShinyBud | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $598.07K | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $423.45K | -4.9x | -0.05 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kiaro Holdings | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $221.07K | -0x | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |